Search results
Results from the WOW.Com Content Network
Sodium ferrocyanide is produced industrially from hydrogen cyanide, ferrous chloride, and calcium hydroxide, the combination of which affords Ca 2 [Fe(CN) 6]·11H 2 O.A solution of this salt is then treated with sodium salts to precipitate the mixed calcium-sodium salt CaNa 2 [Fe(CN) 6] 2, which in turn is treated with sodium carbonate to give the tetrasodium salt.
Non-small cell lung cancer, oesophageal cancer, uterine cervical cancer, head and neck cancer and urothelial cancer: Nephrotoxicity, myelosuppression and nausea and vomiting (30-90%). Oxaliplatin: IV: Reacts with DNA, inducing apoptosis, non-cell cycle specific. Colorectal cancer, oesophageal cancer and gastric cancer
Ferrocyanide is the name of the anion [Fe 6] 4−. Salts of this coordination complex give yellow solutions. It is usually available as the salt potassium ferrocyanide , which has the formula K 4 Fe(CN) 6 .
Advocates assume the diet avoids "fuelling" cancer tumours and say the diet can be used as a substitute for convention treatment, but their claims are not supported by medical evidence. [ 23 ] Kousmine diet – a restrictive diet devised by Catherine Kousmine (1904–1992) which emphasized fruit, vegetables, grains, pulses and the use of ...
Because of the high stability of their complexation with iron, ferrocyanides (Sodium ferrocyanide E535, Potassium ferrocyanide E536, and Calcium ferrocyanide E538 [45]) do not decompose to lethal levels in the human body and are used in the food industry as, e.g., an anticaking agent in table salt.
1900 – Swedish Dr. Stenbeck cures a skin cancer with small doses of radiation [4]; 1920s – Dr. William B. Coley's immunotherapy treatment, regressed tumors in hundreds of cases, the success of Coley's Toxins attracted heavy resistance from his rival and supervisor, Dr. James Ewing, who was an ardent supporter of radiation therapy for cancer.
This is a type of targeted therapy which uses the physical, chemical and biological properties of the radiopharmaceutical to target areas of the body for radiation treatment. [3] The related diagnostic modality of nuclear medicine employs the same principles but uses different types or quantities of radiopharmaceuticals in order to image or ...
As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point. [3] It has been said that "α-emitters are indispensable with regard to optimisation of strategies for tumour therapy". [4]